Group Psychotherapy for Mental Health after Amputation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a group therapy program to help individuals with limb loss improve mental health during rehabilitation. The program aims to reduce anxiety and depression by providing a supportive space for sharing experiences and learning coping strategies. Half of the participants will join supportive-expressive group therapy sessions, while the other half will continue with their usual care. The goal is to determine if the group therapy significantly improves mental health. This trial suits English-speaking inpatients at St. John's Rehab with limb loss, who are medically stable and do not have severe mental health issues like active psychosis. As an unphased trial, it offers patients a unique opportunity to contribute to innovative mental health support strategies in rehabilitation settings.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this group therapy program is safe for inpatients with limb loss?
Research shows that supportive-expressive group therapy (SEGT) is generally safe and well-tolerated for people who have lost a limb. In this therapy, participants join group sessions to share experiences and learn coping strategies. Studies have found that these group settings often improve emotional well-being and social connections. Although specific safety data for SEGT in people with limb loss is limited, group therapies like this are usually considered safe. They focus on mental and emotional support rather than physical treatments, so serious side effects are rare. However, as with any therapy, individual experiences can differ, and discussing concerns with healthcare providers is important.12345
Why are researchers excited about this trial?
Researchers are excited about supportive-expressive group therapy for mental health after amputation because it offers a tailored approach that specifically addresses the unique psychological challenges faced by individuals with limb loss. Unlike standard care, which typically involves general psycho-social support and occasional referrals to specialists, this therapy is designed by an interprofessional team to directly target issues related to limb loss. The therapy's focus on fostering emotional expression and support within a group setting aims to enhance coping strategies and emotional well-being, potentially leading to improved mental health outcomes for amputees.
What evidence suggests that this trial's treatments could be effective for mental health after amputation?
Research shows that supportive-expressive group therapy, which participants in this trial may receive, can improve mental health for people who have lost a limb. Studies have found that these group sessions boost emotional well-being and mobility, and they also support learning. Early results suggest that patients in this type of therapy feel less depressed and anxious. The therapy helps patients adjust and cope better after losing a limb. It includes guided discussions led by a psychiatrist and an occupational therapist, where participants share challenges and discover coping strategies. These sessions aim to help patients smoothly reintegrate into their communities.12467
Who Is on the Research Team?
Rosalie Steinberg, MD
Principal Investigator
Sunnybrook Health Sciences Centre
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 who are inpatients at St. John's Rehab with any type and level of limb loss, medically stable, without active psychosis or major unmanaged psychiatric disorders, and no cognitive impairment concerns. They must be able to participate effectively in group therapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including socio-demographics, impairment, and mental health history
Treatment
Participants receive weekly supportive-expressive group therapy (SEGT) sessions for 3 weeks
Discharge Assessment
Participants are assessed 48-72 hours after the intervention ends to evaluate changes in mental health outcomes
Follow-up
Participants are monitored for mental health outcomes 3 months post-discharge
What Are the Treatments Tested in This Trial?
Interventions
- Supportive-expressive group therapy
- Treatment as usual
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor